Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by BaconIsBadon Dec 16, 2016 11:42am
268 Views
Post# 25610361

Shoppers have approached CGC as well. We have competition.

Shoppers have approached CGC as well. We have competition.

 

16 Dec 2016 11:35 ET  

 

11:35 AM EST, 12/16/2016 (MT Newswires) -- Pharma industry may be a player in the marijuana market. A lot of innovation happens in the smaller start ups, which may then be acquired by the larger players.

At least two players in the industry have told BNN that they have been approached by Shoppers Drug Mart. Malik also anticipates that London Drugs and other pharmacy chains may be involved in the long run.

Bullboard Posts